Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-09 10:05 am Sale | 13G | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | FMR LLC | 1,155,033 10.054% | -91,653 (-7.35%) | View |
| 2024-01-16 5:22 pm Purchase | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 3,633,743 31.600% | 103,200 (+2.92%) | View |
| 2023-02-09 12:46 pm Purchase | 13G | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | FMR LLC | 1,246,686 10.887% | 83,598 (+7.19%) | View |
| 2022-08-10 08:10 am Purchase | 13G | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | FMR LLC | 1,163,088 10.183% | 275,566 (+31.05%) | View |
| 2022-02-14 5:20 pm Sale | 13G | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | Eagle Point Credit Management LLC | 0 0.000% | -149,248 (Position Closed) | View |
| 2022-02-09 10:04 am Purchase | 13G | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | FMR LLC | 887,522 7.846% | 887,522 (New Position) | View |
| 2021-04-19 4:53 pm Purchase | 13G | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | Eagle Point Credit Management LLC | 149,248 6.300% | 149,248 (New Position) | View |
| 2021-04-02 5:16 pm Sale | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 3,530,543 31.400% | -651,700 (-15.58%) | View |
| 2020-12-15 5:21 pm Unchanged | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 37.900% | 0 (Unchanged) | View |
| 2020-10-09 5:20 pm Unchanged | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% | 0 (Unchanged) | View |
| 2020-09-23 5:28 pm Purchase | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% | 156,086 (+3.88%) | View |
| 2020-08-19 4:31 pm Unchanged | 13G | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | NOVARTIS AG NVS | 539,131 4.900% | 0 (Unchanged) | View |
| 2020-04-17 4:54 pm Purchase | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 4,026,157 36.600% | 12,703 (+0.32%) | View |
| 2020-03-17 9:26 pm Purchase | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 4,013,454 36.400% | 118,277 (+3.04%) | View |
| 2020-02-13 5:30 pm Purchase | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 3,895,177 35.400% | 1,252,772 (+47.41%) | View |
| 2019-12-20 7:24 pm Purchase | 13D | XOMA ROYALTY CRP DEP REPSTG 1/ XOMAO | BIOTECHNOLOGY VALUE FUND L P | 2,642,405 27.100% | 873,376 (+49.37%) | View |